Johnson & Johnson – United States of America
BRANDS & DIVISIONS
Aveeno, Bebe, Clean&Clear, Dabao, Dr. Ci:Labo, Exuviance, Le Petit Marseillais, Lubriderm, NeoStrata, Neutrogena, Piz Buin, Sundown, Maui Moisture, OGX, Regaine Rogaine
Aveeno Baby, BAND-AID, Carefree, Desitin, Johnson’s, LISTERINE, Neosporin, O.B., PENATEN, Stayfree
Total Consumer Health
Sales: $15 billion,
+2.7% vs. 2021
U.S. skin health/beauty
sales: $2.3 billion,
-4.2% vs. 2021.
International skin health/
beauty sales: $2 billion,
-5.9% vs. 2021
JOHNSON & JOHNSON CONSUMER HEALTH SALES: $14.6 billion, +4.1% vs. 2020 U.S.: 53% of beauty sales (EST.) TOP INTERNATIONAL MARKETS: China and Japan
ESG Commitments
Health for Humanity 2025 Goals
- Champion global health equity
- Empower our employees
- Advance enviromental health
- Lead with accountability and innovation
ESG Progress Reports
DI&E Commitments
Board of Directors
- 93% independent
- 35.7% women
- 21.4% ethnically/racially diverse
- Supporting healthcare for women
- Improving maternal health among Black mothers
- Ongoing medical safety excellence during COVID-19
- Focusing on child safety
- Promoting patient preference studies
- Talc safety
Information Security & Data Privacy
In 2021, in addition to ongoing programs and controls, our focus included:
- Proactive cyber protection for our COVID-19 vaccine information
- Increased security capabilities at critical manufacturing sites and product certifications
- Maintaining global cybersecurity and privacy compliance
- Maintaining awareness and vigilance among our employees
